Health and Human Services News and Research

RSS

FDA approves new drug to treat thrombocytopenia in adults with chronic liver disease

The U.S. Food and Drug Administration today approved Doptelet (avatrombopag) tablets to treat low blood platelet count (thrombocytopenia) in adults with chronic liver disease who are scheduled to undergo a medical or dental procedure. This is the first drug approved by the FDA for this use.

22 May 2018

Women with gestational diabetes may be at greater risk for chronic kidney disease

Gestational diabetes may predispose women to early-stage kidney damage, a precursor to chronic kidney disease, according to a study by researchers at the National Institutes of Health and other institutions. The study appears in Diabetes Care.

21 May 2018

Scientists identify new drug target to combat chikungunya virus

Scientists have identified a molecule found on human cells and some animal cells that could be a useful target for drugs against chikungunya virus infection and related diseases, according to new research published in the journal Nature.

21 May 2018

Study finds age-related racial disparities in youth suicide

New research suggests the suicide rate is roughly two times higher for black children ages 5-12 compared with white children of the same age group. The study, funded by the National Institute of Mental Health (NIMH), appears online May 21 in JAMA Pediatrics.

21 May 2018

Clinical trial begins enrollment to test safety of experimental MERS treatments

Enrollment has begun in an early-stage clinical trial testing the safety of two human monoclonal antibodies (mAbs) designed to treat people infected with Middle East respiratory syndrome coronavirus (MERS-CoV).

18 May 2018

Vermont legislators pass a drug importation law. So what?

This week, Vermont passed a first-in-the-nation law that would facilitate the state's importation of prescription drugs wholesale from Canada. It represents the state's effort to tackle head-on the issue of constantly climbing drug prices.

18 May 2018

Experts available to discuss subjects related to Ebola virus

Georgetown University Medical Center (GUMC) professors offer expertise for journalists seeking interviews in a variety of subjects related to Ebola.

18 May 2018

Microglia may play key role in slowing progression of prion diseases, research suggests

Prion diseases are slow degenerative brain diseases that occur in people and various other mammals. No vaccines or treatments are available, and these diseases are almost always fatal. Scientists have found little evidence of a protective immune response to prion infections.

17 May 2018

Drug combination may prevent secondary stroke in certain patients, study shows

Results from an international clinical trial of more than 4880 participants, published in the New England Journal of Medicine, show that combining clopidogrel and aspirin following a small stroke or experiencing minor stroke symptoms decreases risk of a new stroke, heart attack or other ischemic event within 90 days.

17 May 2018

FDA approves new treatment to mitigate opioid withdrawal symptoms in adults

The U.S. Food and Drug Administration today approved Lucemyra (lofexidine hydrochloride) for the mitigation of withdrawal symptoms to facilitate abrupt discontinuation of opioids in adults.

17 May 2018

Reversing an overdose isn’t complicated, but getting the antidote can be

A few months ago, Kourtnaye Sturgeon helped save someone’s life. She was driving in downtown Indianapolis when she saw people gathered around a car on the side of the road. Sturgeon pulled over, and a man told her there was nothing she could do: Two men had overdosed on opioids and appeared to be dead.

16 May 2018

First epoetin alfa biosimilar receives FDA approval to treat certain types of anemia

The U.S. Food and Drug Administration today approved Retacrit (epoetin alfa-epbx) as a biosimilar to Epogen/Procrit (epoetin alfa) for the treatment of anemia caused by chronic kidney disease, chemotherapy, or use of zidovudine in patients with HIV infection.

16 May 2018

NIH researchers develop new tool to better understand brain disorders

A new tool developed by researchers at the National Institutes of Health has determined, for the first time, how two distinct sets of neurons in the mouse brain work together to control movement.

14 May 2018

FDA approves new drug to treat MS in pediatric patients

The U.S. Food and Drug Administration today approved Gilenya (fingolimod) to treat relapsing multiple sclerosis (MS) in children and adolescents age 10 years and older. This is the first FDA approval of a drug to treat MS in pediatric patients.

14 May 2018

Trump vows (again) to lower drug prices but skeptics doubt much will change

President Donald Trump, armed with the expertise of staff seasoned in the ways of the drug industry, unveiled his blueprint to address sky-high drug prices Friday afternoon, promising that increasing industry competition will help Americans save at the pharmacy counter.

11 May 2018

Study uncovers new circuit that fine tunes brain's decision to hide or confront threats

In a study of mice, National Institutes of Health-funded researchers describe a new circuit involved in fine-tuning the brain's decision either to hide or confront threats.

11 May 2018

Midterm elections are shaping up to be a referendum on Trumpism

Voters looking toward the midterm elections are more motivated by a candidate's stance on President Donald Trump than on any specific policy question.

10 May 2018

FDA seeks order of permanent injunction to stop two stem cell clinics from marketing stem cell products

The U.S. Food and Drug Administration, in two complaints filed today in federal court, is seeking permanent injunctions to stop two stem cell clinics from marketing stem cell products without FDA approval and for significant deviations from current good manufacturing practice requirements.

10 May 2018

Students, faculty members attend CSU Health Policy Conference held in Sacramento

The CSU educates thousands of public health professionals who work to improve the health of California's communities by promoting healthy lifestyles, preventing disease and removing environmental dangers.

10 May 2018

Mutations in EBOV-Makona do not alter disease-causing ability in animal models, shows study

Early during the recent Ebola epidemic in West Africa, scientists speculated that the genetic diversity of the circulating Makona strain of virus (EBOV-Makona) would result in more severe disease and more transmissibility than prior strains.

9 May 2018

Health and Human Services News and Research

FDA approves new drug to treat thrombocytopenia in adults with chronic liver disease

Women with gestational diabetes may be at greater risk for chronic kidney disease

Scientists identify new drug target to combat chikungunya virus

Study finds age-related racial disparities in youth suicide

Clinical trial begins enrollment to test safety of experimental MERS treatments

Vermont legislators pass a drug importation law. So what?

Experts available to discuss subjects related to Ebola virus

Microglia may play key role in slowing progression of prion diseases, research suggests

Drug combination may prevent secondary stroke in certain patients, study shows

FDA approves new treatment to mitigate opioid withdrawal symptoms in adults

Reversing an overdose isn’t complicated, but getting the antidote can be

First epoetin alfa biosimilar receives FDA approval to treat certain types of anemia

NIH researchers develop new tool to better understand brain disorders

FDA approves new drug to treat MS in pediatric patients

Trump vows (again) to lower drug prices but skeptics doubt much will change

Study uncovers new circuit that fine tunes brain's decision to hide or confront threats

Midterm elections are shaping up to be a referendum on Trumpism

FDA seeks order of permanent injunction to stop two stem cell clinics from marketing stem cell products

Students, faculty members attend CSU Health Policy Conference held in Sacramento

Mutations in EBOV-Makona do not alter disease-causing ability in animal models, shows study

Event guide: 6th Operationalize Expanded Access Programs Summit East eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News